Entropy Technologies LP purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 33,219 shares of the medical instruments supplier's stock, valued at approximately $630,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in XRAY. Creative Planning raised its holdings in DENTSPLY SIRONA by 53.9% during the 2nd quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier's stock valued at $412,000 after buying an additional 5,793 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter valued at $481,000. GAMMA Investing LLC raised its holdings in DENTSPLY SIRONA by 133.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier's stock valued at $67,000 after buying an additional 1,422 shares during the last quarter. CWM LLC increased its position in DENTSPLY SIRONA by 118.2% during the 3rd quarter. CWM LLC now owns 7,337 shares of the medical instruments supplier's stock valued at $199,000 after purchasing an additional 3,975 shares during the period. Finally, UMB Bank n.a. increased its position in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after purchasing an additional 753 shares during the period. 95.70% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on XRAY shares. Morgan Stanley reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday, December 17th. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research report on Friday, November 8th. Ten investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus target price of $25.85.
Read Our Latest Research Report on XRAY
DENTSPLY SIRONA Stock Down 2.4 %
Shares of NASDAQ:XRAY traded down $0.45 during midday trading on Friday, reaching $18.32. The company's stock had a trading volume of 2,580,852 shares, compared to its average volume of 2,164,900. The firm has a market capitalization of $3.64 billion, a P/E ratio of -8.85, a PEG ratio of 1.83 and a beta of 0.96. The firm has a 50 day moving average of $19.02 and a 200-day moving average of $21.93. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $34.91. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.
DENTSPLY SIRONA Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's payout ratio is -30.92%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.